Responses
Abstract
Posters October 5
NEUROPROTECTION WITH AMIFOSTINE IN THE 1ST-LINE TREATMENT OF ADVANCED OVARIAN CANCER WITH CARBOPLATIN/TAXANE-BASED CHEMOTHERAPY – A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE II-STUDY FROM THE AGO OVARIAN CANCER STUDY GROUP
Compose a Response to This Article
Other responses
No responses have been published for this article.